Advertisement

Esperion Therapeutics, Inc. ESPR

Set alert

Price alert · ESPR

All alert types
3.18 USD 0.00 0.00%

At close · Jul 13

3.15 -0.03 -0.94%

After hours · Jul 13, 4:00 PM ET

Bid
3.15 × 2
Ask
3.16 × 2
3.18 Day range 3.18
1.58 52-week range 3.94
YTD
-14.05%
1 year
+211.76%
Open
3.18
Prev close
3.18
Mkt cap
441.36M
Vol
0
Avg vol
5.64M
EPS
-0.67
P/E
0.00
Div yield
0.00%
More statistics
Low
3.18
High
3.18
Forward P/E
11.20
Beta
0.95
Short ratio
5.70
Inst. own
66.34%
Dividend
0.00
Ex-div date
50-d avg
2.41
200-d avg
2.24
1y target
7.51

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ESPR has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Product → Revenue: $43.39MRevenue → Gross Profit: $45.53MGross Profit → Expenses: $45.53MRevenue → Cost of Revenue: $34.57MExpenses → Selling, General & Admin: $43.12MExpenses → Research & Development: $8.99MExpenses → Other Expenses: $18.61MCollaboration Revenue → Revenue: $36.71MNet Loss → Expenses: $25.20MGross Profit$45.53MNet Loss$25.20MCost of Revenue$34.57MExpenses$70.73MSelling, General & Admin$43.12MResearch & Development$8.99MOther Expenses$18.61MRevenue$80.10MProduct$43.39MCollaboration Revenue$36.71M

Period ending Mar 31, 2026 · select a line to chart its history

Income statement

ESPR quarterly income statement
80.10M
80.10M
34.57M
45.53M
52.11M
8.99M
43.12M
-6.58M
19.80M
-25.20M
-25.20M
-25.20M
-25.20M
-0.10
-0.10
-0.10
-5.40M
-5.40M
251.35M
251.35M

Balance sheet

ESPR quarterly balance sheet
156.16M
156.16M
132.35M
459.46M
3.01M
462.53M
82.44M
543.81M
300.36M
461.36M
770.46M
-1.65B
-307.93M
-307.93M
3.07M
543.81M
43.53M
56.00K
104.21M
470.10M
68.41M

Cash flow

ESPR quarterly cash flow
27.00K
16.22M
-11.69M
-189.00K
16.22M
-189.00K
-27.72M
2.50M
Advertisement